Nanosyn Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 75

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

  • Investments
  • 2

Nanosyn General Information

Description

Provider of chemistry and biology services catering to small to mid-sized pharma and biotech companies. The company offers contract development and manufacturing, custom synthesis, process research and development, formulation and biology services, thereby helping customers from early-stage discovery, through clinical trials, formulation and regulatory approval.

Contact Information

Website
www.nanosyn.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • 3100 Central Expressway
  • Santa Clara, CA 95051
  • United States
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 3100 Central Expressway
  • Santa Clara, CA 95051
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanosyn Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nanosyn‘s full profile, request access.

Request a free trial

Nanosyn Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of chemistry and biology services catering to small to mid-sized pharma and biotech companies. The company offe
Drug Discovery
Santa Clara, CA
75 As of 2021

Krakow, Poland
 

Illkirch, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanosyn Competitors (48)

One of Nanosyn’s 48 competitors is Selvita, a Corporation company based in Krakow, Poland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Selvita Corporation Krakow, Poland
Prestwick Chemical Corporate Backed or Acquired Illkirch, France
Inotiv Formerly PE-Backed West Lafayette, IN
Sygnature Discovery Private Equity-Backed Nottingham, United Kingdom
Evotec Formerly PE-Backed Hamburg, Germany
You’re viewing 5 of 48 competitors. Get the full list »

Nanosyn Patents

Nanosyn Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11339126-B2 Compounds for the reducing lipotoxic damage Active 12-Jul-2017
US-11623915-B2 Compounds for the reducing lipotoxic damage Active 12-Jul-2017
US-20210139421-A1 Compounds for the reducing lipotoxic damage Active 12-Jul-2017
US-20220324797-A1 Compounds for the reducing lipotoxic damage Active 12-Jul-2017
WO-2018175906-A1 Fused triazolo-pyrimidine compounds having useful pharmaceutical application Inactive 24-Mar-2017 C07D487/04
To view Nanosyn’s complete patent history, request access »

Nanosyn Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanosyn Acquisitions (2)

Nanosyn’s most recent deal was a Merger/Acquisition with Seres Labratories. The deal was made on 01-Mar-2009.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Seres Labratories 01-Mar-2009 Merger/Acquisition Other Commercial Services
Amphora Discovery 21-Oct-2008 Merger/Acquisition Drug Discovery
To view Nanosyn’s complete acquisitions history, request access »

Nanosyn FAQs

  • When was Nanosyn founded?

    Nanosyn was founded in 1998.

  • Where is Nanosyn headquartered?

    Nanosyn is headquartered in Santa Clara, CA.

  • What is the size of Nanosyn?

    Nanosyn has 75 total employees.

  • What industry is Nanosyn in?

    Nanosyn’s primary industry is Drug Discovery.

  • Is Nanosyn a private or public company?

    Nanosyn is a Private company.

  • What is Nanosyn’s current revenue?

    The current revenue for Nanosyn is .

  • Who are Nanosyn’s competitors?

    Selvita, Prestwick Chemical, Inotiv, Sygnature Discovery, and Evotec are some of the 48 competitors of Nanosyn.

  • When was Nanosyn acquired?

    Nanosyn was acquired on 11-Oct-2021.

  • Who acquired Nanosyn?

    Nanosyn was acquired by Element Materials Technology (London).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process